Serious conditions behind bloody cough symptoms revealed. Life-threatening diseases that cause alarming blood in cough ...

Motion sickness is a common issue for both dogs and cats, often affecting pets during car rides, boat trips, or even short ...

The American Heart Association (AHA) suggests that persistent, or chronic, cough is a common symptom of Congestive Heart Failure (CHF ... However, with the right tests and timely treatment, it’s ...

Angiotensin II Receptor Blockers in the Treatment of Heart Failure Ross C. Peterson, MD, Mark E. Dunlap, MD Disclosures CHF. 2002;8 (5) Clinical Benefits of ARB Therapy in the Treatment of Heart ...

Although overall technically easier than double-lung transplantation, heart-lung transplantation prevalence among patients with congenital heart disease has declined significantly worldwide over the ...

While a cough might seem like a small problem, in the case of heart failure, it can be a sign that your body is struggling to cope. If it happens along with other symptoms like feeling tired, short of ...

Hypertension, also known as high blood pressure, is a condition where the force of blood against your artery walls is consistently high. A chronic and serious condition, High BP can be controlled ...

Divi's Laboratories in focus after Novartis-MSN settle patent on heart failure treatment drug In case MSN launches the generic version of the drug in July 2025, Divi's Laboratories' estimated earnings ...

THOMPSON, Conn. (WTNH) — Kevin Vigeant of Thompson was just 34 years old when he was diagnosed with congestive heart failure this past March. “Normal activities, I would be short o… ...

PDE3 inhibitors are already in clinical use for treating heart failure, thrombosis, asthma, and other conditions, but their potential in promoting bone outgrowth by enhancing CNP signaling remained ...

Understand what congestive heart failure (CHF) is and learn to recognise early symptoms like fatigue, swelling, and breathlessness.

Eli Lilly & Co. aims to offer a one-and-done heart-disease medicine by paying up to $1.3 billion for Verve Therapeutics Inc., the maker of a new gene-editing treatment, Lilly said on Tuesday.